Finance

Lists
BAK:NYSE
Braskem SA ADR Class A
$1.65
+0.92%
(+0.015) 1D
Aug 28, 9:55:36 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAK...
Open
$1.64
High
$1.67
Low
$1.58
Mkt. cap
573.64M
Avg. vol.
2.38M
Volume
6.44K
52-wk high
$5.40
52-wk low
$1.40
EPS
-$2.70
Beta
1.67
Shares outstanding
172.53M
No. of employees
8K
Open
$1.64
High
$1.67
Low
$1.58
Mkt. cap
573.64M
Avg. vol.
2.38M
Volume
6.44K
52-wk high
$5.40
52-wk low
$1.40
EPS
-$2.70
Beta
1.67
Shares outstanding
172.53M
No. of employees
8K
News stories
From web sources and news partners
Profile
Braskem S.A is a Brazilian petrochemical company headquartered in São Paulo. The company is the largest petrochemical company in Latin America and has become a major player in the international petrochemical market. Wikipedia
About Braskem SA ADR Class A
CEORoberto Prisco Ramos
Employees8.23K
FoundedAug 16, 2002
Headquarters-
SectorCommodity chemical
Websitebraskem.com.br
Analyst ratings
Based on 2 analysts giving stock ratings to BAK in the past 3 months
Sell
Buy
0
Hold
1
Sell
1
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for BAK in the last 3 months.
Highest
Current $1.65
(-100.00%)
Average
(-100.00%)
Lowest
(-100.00%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonardo Marcondes
Bank of America Securities
Sell
Maintained
-
-
07/15/2026
Milene Carvalho
J.P. Morgan
Hold
Downgraded
-
-
06/30/2026
Vicente Falanga
Bradesco
Sell
Downgraded
$1.50
-9.1%
04/21/2026
Rodrigo Reis de Almeida
BTG Pactual
Sell
Downgraded
$2.80
+69.7%
10/15/2025
Last report
Aug 14, 2026
Fiscal period
Q2 2026
EPS / Est. (BRL)
R$8.34 / -
0.00%miss
Revenue / Est. (BRL)
21.72B / 23.75B
-8.56%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
17.30B
16.10B
15.49B
21.72B
Cost of goods sold
16.86B
14.82B
14.39B
16.40B
Cost of revenue
16.86B
14.82B
14.39B
16.40B
Research and development expenses
121.00M
105.00M
102.00M
103.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.11B
1.17B
1.22B
1.21B
Operating expense
2.11B
-1.13B
1.26B
1.25B
Total operating expenses
18.97B
13.69B
15.65B
17.65B
Operating income
-1.67B
2.41B
-160.00M
4.06B
Other non operating income
311.00M
776.00M
-245.00M
1.12B
EBT including unusual items
-2.59B
-540.00M
953.00M
3.56B
EBT excluding unusual items
-2.59B
1.61B
1.07B
3.56B
Income tax expense
-2.42B
10.49B
-293.00M
238.00M
Effective tax rate
93.28%
-1,942.41%
-30.75%
6.68%
Other operating expenses
741.00M
-2.40B
-56.00M
-62.00M
Net income
-26.00M
-10.28B
1.45B
3.32B
Net profit margin
-0.15%
-63.88%
9.34%
15.31%
Earnings per share
0.01
-
1.48
-
Interest and investment income
384.00M
143.00M
136.00M
-
Interest expense
-1.60B
-1.50B
-1.34B
-1.61B
Net interest expenses
-1.22B
-1.36B
-1.20B
-1.61B
Depreciation and amortization charges
-
-
-
-
EBITDA
-827.00M
3.31B
795.00M
5.44B
Gain or loss from assets sale
-
-24.00M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps